EGFR and lung adenocarcinoma: We set to establish an appropriate preclinical orthotopic mouse model using luciferase tagged lung adenocarcinoma PC9 cells, harboring EGFR TKI sensitive exon 19 deletion, injected through a tail vein to model and extend the implications of the ADAURA trial.